Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN
|
February 6, 2026
Practical Considerations for Infection Prevention With the Clinical Use of Complement Inhibitors
Anuja Java, Aruna Subramanian, Carla Nester
Pediatric Nephrology (Berlin, Germany)
|
February 20, 2026
A nephritic puzzle: C3-dominant glomerulonephritis as a sentinel of hidden autoinflammatory disease
Ryan C Ward, Polly Ferguson, Prerna Rastogi, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
May 28, 2011
Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome
Carla Nester, Zoe Stewart, David Myers, et al.
Pediatric Research
|
December 15, 2024
Extrarenal manifestations of atypical hemolytic uremic syndrome: a systematic review and meta-analysis
Kush Doshi, Abdel Yusuf, Christoph Licht, et al.
Pediatric Nephrology (Berlin, Germany)
|
December 9, 2025
Incidence and severity of extrarenal manifestations and outcomes in pediatric hemolytic uremic syndrome: a retrospective cohort study
Rupesh Raina, Keval Yerigeri, Kush Doshi, et al.
Journal of the American Society of Nephrology : JASN
|
November 1, 2018
Genetic Analysis of 400 Patients Refines Understanding and Implicates a New Gene in Atypical Hemolytic Uremic Syndrome
Fengxiao Bu, Yuzhou Zhang, Kai Wang, et al.
Journal of the American Society of Nephrology : JASN
|
August 19, 2015
High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies
Fengxiao Bu, Nicolo Ghiringhelli Borsa, Michael B Jones, et al.
American Journal of Nephrology
|
November 21, 2022
Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan
Steven D Podos, Howard Trachtman, Gerald B Appel, et al.
Kidney International Reports
|
December 18, 2023
Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy
Edwin Wong, Carla Nester, Teresa Cavero, et al.
Pediatric Nephrology (Berlin, Germany)
|
April 11, 2015
An international consensus approach to the management of atypical hemolytic uremic syndrome in children
Chantal Loirat, Fadi Fakhouri, Gema Ariceta, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Clinical Journal of the American Society of Nephrology : CJASN
|
February 6, 2026
Practical Considerations for Infection Prevention With the Clinical Use of Complement Inhibitors
Anuja Java, Aruna Subramanian, Carla Nester
Pediatric Nephrology (Berlin, Germany)
|
February 20, 2026
A nephritic puzzle: C3-dominant glomerulonephritis as a sentinel of hidden autoinflammatory disease
Ryan C Ward, Polly Ferguson, Prerna Rastogi, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
May 28, 2011
Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome
Carla Nester, Zoe Stewart, David Myers, et al.
Pediatric Research
|
December 15, 2024
Extrarenal manifestations of atypical hemolytic uremic syndrome: a systematic review and meta-analysis
Kush Doshi, Abdel Yusuf, Christoph Licht, et al.
Pediatric Nephrology (Berlin, Germany)
|
December 9, 2025
Incidence and severity of extrarenal manifestations and outcomes in pediatric hemolytic uremic syndrome: a retrospective cohort study
Rupesh Raina, Keval Yerigeri, Kush Doshi, et al.
Journal of the American Society of Nephrology : JASN
|
November 1, 2018
Genetic Analysis of 400 Patients Refines Understanding and Implicates a New Gene in Atypical Hemolytic Uremic Syndrome
Fengxiao Bu, Yuzhou Zhang, Kai Wang, et al.
Journal of the American Society of Nephrology : JASN
|
August 19, 2015
High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies
Fengxiao Bu, Nicolo Ghiringhelli Borsa, Michael B Jones, et al.
American Journal of Nephrology
|
November 21, 2022
Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan
Steven D Podos, Howard Trachtman, Gerald B Appel, et al.
Kidney International Reports
|
December 18, 2023
Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy
Edwin Wong, Carla Nester, Teresa Cavero, et al.
Pediatric Nephrology (Berlin, Germany)
|
April 11, 2015
An international consensus approach to the management of atypical hemolytic uremic syndrome in children
Chantal Loirat, Fadi Fakhouri, Gema Ariceta, et al.
Page
of 2